InnoCan Pharma Corporation
INNO
Rankning i aktier
#33926
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Aktiekurs
$1.35
Senast synkroniserad: 2026-10-19
Marknadsvärde
$6.08M
Förändring (1 dag)
-3.08%
Förändring (1 år)
-89.20%
Land
CA
Handel InnoCan Pharma Corporation (INNO)
Kategori
Healthcare
Aktiekurshistorik för InnoCan Pharma Corporation (INNO)
Högsta slutkurs: $1.37 den 2026-10-01
Lägsta slutkurs: $11.93 den 2020-11-01
Lägsta slutkurs: $11.93 den 2020-11-01
Aktiekurshistorik för InnoCan Pharma Corporation från 2020 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -38.79% |
| 2025 | -29.02% |
| 2024 | -47.91% |
| 2023 | 42.26% |
| 2022 | -67.12% |
| 2021 | 201.26% |
| 2020 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $164.02 | 22.66% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $223.71 | 30.64% |
CH
|
|
| $18.43 | -4.03% |
IN
|
